Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.
Hiroaki Shiba(Jikei University School of Medicine), Katsuhiko Yanaga(Jikei University School of Medicine), Kenei Furukawa(Jikei University School of Medicine), Yuichi Ishida(Jikei University School of Medicine), Shigeki Wakiyama(Jikei University School of Medicine), Koichiro Haruki(Jikei University School of Medicine), Tomonori lida, Nobuhiro Tsutsui, Michinori Matsumoto(Jikei University School of Medicine), Takeyuki Misawa(Jikei University School of Medicine), Takeshi Gocho(Jikei University School of Medicine), Yuki Fujiwara(University of Colorado Anschutz Medical Campus), Shoichi Hirohara(Jikei University School of Medicine), Ryusuke Ito(Jikei University School of Medicine), Taro Sakamoto(Jikei University School of Medicine)
PubMed
October 1, 2013
Cited by 13
Related Papers
Negative Impact of Blood Transfusion on Recurrence and Prognosis of Hepatocellular Carcinoma After Hepatic Resection
|Journal of Gastrointestinal Surgery|2009|95
Utility of augmented reality system in hepatobiliary surgery
|Journal of Hepato-Biliary-Pancreatic Sciences|2012|47
Impact of C-reactive protein–albumin–lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis
|Surgical Oncology|2023|46
The GPR171 pathway suppresses T cell activation and limits antitumor immunity
|Nature Communications|2021|31